Aptamer Group Ltd.. (8/25/21). "Press Release: Aptamer Group and Bio-Works Technologies Partner to Enable Improved Solutions for Gene Therapy Manufacturing". York & Uppsala. |
2021-08-25 |
Valneva S.E.. (8/23/21). "Press Release: Valneva Commences Rolling Submission to MHRA for its Inactivated, Adjuvanted COVID-19 Vaccine". Saint-Herblain. |
2021-08-23 |
Exscientia Ltd.. (8/18/21). "Press Release: Bristol Myers Squibb Exercises Option to Develop Exscientia’s AI-designed, Immune-modulating Drug Candidate". Oxford. |
2021-08-18 |
ERS Genomics Ltd.. (8/17/21). "Press Release: ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement". Dublin & Coralville, IA. |
2021-08-17 |
Ultromics Ltd.. (8/16/21). "Press Release: Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment". Oxford. |
2021-08-16 |
Beckley Psytech Ltd.. (8/15/21). "Press Release: Beckley Psytech Completes Oversubscribed $80m (£58m) Fundraise to Develop Portfolio of Psychedelic Medicine Breakthroughs". Oxford. |
2021-08-15 |
Monument Therapeutics Ltd.. (8/11/21). "Press Release: Digital Brain Biomarker Start-up Monument Therapeutics Appoints Acacia and Arakis Founder Julian Gilbert to Board". Manchester. |
2021-08-11 |
Mission Therapeutics Ltd.. (8/9/21). "Press Release: Mission and AbbVie Collaboration in Alzheimer’s and Parkinson’s Diseases Reaches Next Milestone- Mission Receives $20 Million Milestone payment". Cambridge. |
2021-08-09 |
SolasCure Ltd.. (8/9/21). "Press Release: SolasCure Announces £15m Series A Raise". |
2021-08-09 |
Exscientia Ltd.. (8/4/21). "Press Release: Exscientia Builds Automated Laboratories in Oxford to Expand Pipeline". |
2021-08-04 |
Mestag Therapeutics Ltd.. (8/3/21). "Press Release: Mestag Therapeutics Extends Seed Financing to $45 Million and Welcomes New Investors Forbion, GV (formerly Google Ventures) and Northpond Ventures". Cambridge. |
2021-08-03 |
Abcam plc. (8/2/21). "Press Release: Abcam to Acquire BioVision for $340 Million". Cambridge. |
2021-08-02 |
BiVictriX Therapeutics plc. (8/2/21). "Press Release: Intention to Float on AIM [Not for US, AU, CA, et al.]". Alderley Park. |
2021-08-02 |
Synthace Ltd.. (8/2/21). "Press Release: Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility for Scientists". London. |
2021-08-02 |
SynOx Therapeutics Ltd.. (7/27/21). "Press Release: SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer". Dublin. |
2021-07-27 |
Artios Pharma Ltd.. (7/27/21). "Press Release: Artios Announces $153 Million (£110 Million) Series C Financing Led by Omega Funds and TCG X". Cambridge & New York, NY. |
2021-07-27 |
Metrion Biosciences Ltd.. (7/26/21). "Press Release: Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development". Cambridge. |
2021-07-26 |
Exscientia Ltd.. (7/21/21). "Press Release: Exscientia and GT Apeiron Therapeutics Enter Oncology Joint Venture". Oxford & Shanghai. |
2021-07-21 |
BioIVT LLC. (7/19/21). "Press Release: BioIVT Acquires Tissue Solutions Ltd., a UK-based Virtual Biobank". Westbury, NY. |
2021-07-19 |
NanoSyrinx Ltd.. (7/19/21). "Press Release: NanoSyrinx Raises £6.2m to Develop Its Synthetic Biology Platform for Targeted Intracellular Engineering". Coventry. |
2021-07-19 |
Oxford Biomedica plc. (7/15/21). "Press Release: Oxford Biomedica Appoints Dr. Michael Hayden as Non-Executive Director". Oxford. |
2021-07-15 |
Digital Science. (7/15/21). "Press Release: Digital Science Partners with OntoChem GmbH to Better Support Life Sciences Industry R&D". London. |
2021-07-15 |
T-Cypher Bio Ltd.. (7/15/21). "Press Release: T-Cypher Bio Announces the Appointment of Thomas Lars Andresen as Chief Executive Officer". Oxford. |
2021-07-15 |
Bicycle Therapeutics plc. (7/13/21). "Press Release: Bicycle Therapeutics Enters Exclusive License and Collaboration Agreement with Ionis to Develop Targeted Oligonucleotide Therapeutics". Cambridge & Boston, MA. |
2021-07-13 |
Exscientia Ltd.. (7/8/21). "Press Release: Exscientia Accelerates COVID-19 Drug Discovery Using AI". Oxford. |
2021-07-08 |
Theolytics Ltd.. (7/8/21). "Press Release: Theolytics Expands Series A Financing and Welcomes M Ventures as a New Investor". Oxford. |
2021-07-08 |
Nerre Therapeutics Ltd.. (7/7/21). "Press Release: Nerre Therapeutics Raises £20 Million in a Series B2 Financing Round". Stevenage. |
2021-07-07 |
Nvidia Corporation. (7/6/21). "Press Release: Nvidia Launches UK’s Most Powerful Supercomputer, for Research in AI and Healthcare". |
2021-07-06 |
Transine Therapeutics Ltd.. (7/5/21). "Press Release: Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO". Cambridge. |
2021-07-05 |
Compass Pathways plc. (7/5/21). "Press Release: Compass Pathways Joins Forces with King’s College London and South London and Maudsley NHS Foundation Trust to Accelerate Psychedelic Research and Develop New Models of Mental Health Care in the UK". London |
2021-07-05 |
Monument Therapeutics Ltd.. (7/1/21). "Press Release: Digital Brain Biomarker Company Monument Therapeutics Raises £2.6 Million". Manchester. |
2021-07-01 |
Cell and Gene Therapy Catapult, The. (6/29/21). "Press Release: Cell and Gene Therapy Catapult to Expand to Edinburgh BioQuarter". Edinburgh. |
2021-06-29 |
Orbit Discovery Ltd.. (6/29/21). "Press Release: Orbit Discovery Appoints Dr Neil Butt as Chief Executive Officer". Oxford. |
2021-06-29 |
Exscientia Ltd.. (6/24/21). "Press Release: EQRx and Exscientia Enter Strategic Drug Creation, Development and Commercialization Collaboration to Accelerate the Advancement of New World-Class Medicines". Cambridge, MA & Oxford. |
2021-06-24 |
Medistrava Consulting. (6/21/21). "Press Release: Medistrava Consulting Adds Industry Leading Strategic Communications Capability to Its International Healthcare Advisory Practice". London. |
2021-06-21 |
Charnwood Molecular Ltd.. (6/21/21). "Press Release: Charnwood Molecular Combines Discovery Biology with Medicinal Chemistry Through the Acquisition of Aurelia Bioscience Ltd". |
2021-06-21 |
Apollo Therapeutics. (6/17/21). "Press Release: Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development". Cambridge. |
2021-06-17 |
Ochre Bio Ltd.. (6/16/21). "Press Release: Ochre Bio Closes $9.6M Seed Financing Led by Khosla Ventures". Oxford. |
2021-06-16 |
Discovery Park Ltd.. (6/15/21). "Press Release: Discovery Park Announces Appointment to New Role of Chief Business Officer. Science Park Expert Jane Kennedy Joins to Drive Growth". Sandwich, Kent. |
2021-06-15 |
Exscientia Ltd.. (6/15/21). "Press Release: Exscientia Acquires Personalised Medicine AI Pioneer Allcyte". |
2021-06-15 |
Actimed Therapeutics Ltd.. (6/10/21). "Press Release: Actimed Therapeutics Announces Successful Closing of £2.5m Extended Seed B Funding Round". London. |
2021-06-10 |
Lifebit Biotech Ltd.. (6/9/21). "Press Release: Boehringer Ingelheim Partners with Lifebit to Detect Global Infectious Disease Outbreaks". London. |
2021-06-09 |
Iksuda Therapeutics Ltd.. (6/7/21). "Press Release: Iksuda Therapeutics Closes $47 Million Financing Round". Newcastle. |
2021-06-07 |
Exscientia Ltd.. (6/3/21). "Press Release: Exscientia Appoints Joanne Xu, Experienced Asian Market Investor, to Board of Directors". Oxford. |
2021-06-03 |
Transine Therapeutics Ltd.. (6/2/21). "Press Release: Transine Therapeutics Closes Extended Seed Funding of £9.1 Million Co-led by Takeda Ventures, Inc. and the Dementia Discovery Fund to Advance Its Novel Class of Therapeutic RNAs". Cambridge. |
2021-06-02 |
Cytiva. (6/2/21). "Press Release: Cytiva Acquires GoSilico to Strengthen Digital Capabilities in Bioprocessing". |
2021-06-02 |
Agilent Technologies Inc.. (6/1/21). "Press Release: Agilent Presents Thought Leader Award to Professor Chris Elliott". Santa Clara, CA. |
2021-06-01 |
Macrophage Pharma Ltd.. (6/1/21). "Press Release: Macrophage Pharma Appoints Dr Venkat Reddy as Chief Executive Officer". Windsor. |
2021-06-01 |
ERS Genomics Ltd.. (6/1/21). "Press Release: Japanese Patent Office Upholds Key Charpentier/Doudna CRISPR Patent and Allows Third". Dublin. |
2021-06-01 |
Pulmocide Ltd.. (5/27/21). "Press Release: Pulmocide Raises $92 Million in a Series C Financing to Fund Registration Program for PC945". London. |
2021-05-27 |
Coulter Partners. (5/26/21). "Press Release: Coulter Partners Secures Chief Executive Officer for Azitra". |
2021-05-26 |
Synthace Ltd.. (5/19/21). "Press Release: Veteran Technology Executive Joins Synthace to Accelerate Its Mission to Revolutionize the Life Science Research Market. Synthace Hires Guy Levy-Yurista as Chief Executive Officer". London. |
2021-05-19 |
Exscientia Ltd.. (5/19/21). "Press Release: Exscientia Announces Multi-target, AI-driven Drug Discovery Collaboration with Bristol Myers Squibb". |
2021-05-19 |
Mestag Therapeutics Ltd.. (5/18/21). "Press Release: Mestag Therapeutics Announces Collaboration with Janssen, Focused on the Discovery of Novel Fibroblast Targets for the Treatment of Inflammatory Disease". Cambridge. |
2021-05-18 |
Exscientia Ltd.. (5/13/21). "Press Release: Exscientia Announces Second Molecule Created Using AI from Sumitomo Dainippon Pharma Collaboration to Enter Phase 1 Clinical Trial". |
2021-05-13 |
ImaginAb, Inc.. (5/12/21). "Press Release: ImaginAb, Inc. Forms European Subsidiary and Appoints General Manager-Europe". Los Angeles, CA & San Diego, CA. |
2021-05-12 |
Crescendo Biologics Ltd.. (5/10/21). "Press Release: Crescendo Biologics further Strengthens Leadership Team with Appointment of Dr Michael Booth as Chief Financial Officer". Cambridge. |
2021-05-10 |
Abingworth LLP. (5/10/21). "Press Release: Abingworth Raises $582 Million for New Clinical Co-Development Fund – ACCD 2". London. |
2021-05-10 |
Inivata Ltd.. (5/5/21). "Press Release: Inivata to be Acquired by NeoGenomics. Exercise of Purchase Option to Acquire Remaining Inivata Equity Interest for $390m". Research Triangle Park, NC & Cambridge. |
2021-05-05 |
IP Group plc. (5/4/21). "Press Release: Portfolio Company Oxford Nanopore Technologies Raises £195m in New Investment". |
2021-05-04 |
Autolomous Ltd.. (5/4/21). "Press Release: Autolomous Receives Loan from UK Research and Innovation to Expedite the Digitization of Batch Verification in Cell and Gene Therapy manufacturing". London. |
2021-05-04 |
Mogrify Ltd.. (5/4/21). "Press Release: Mogrify Completes Series A financing Totaling $33 Million USD". Cambridge. |
2021-05-04 |
Compass Pathways plc. (4/30/21). "Press Release: Compass Pathways Announces Pricing of Public Offering". London. |
2021-04-30 |
Osteolabs GmbH. (4/29/21). "Press Release: Osteolabs GmbH Establishes UK Presence". Kiel & Marlow. |
2021-04-29 |
Inivata Ltd.. (4/28/21). "Press Release: Inivata and Agendia Sign Agreement for Commercialization of RaDaR MRD Liquid Biopsy Assay in Breast Cancer". Research Triangle Park, NC, Cambridge, Irvine, CA & Amsterdam. |
2021-04-28 |
Exscientia Ltd.. (4/27/21). "Press Release: Exscientia Announces Investment of up to $525M". |
2021-04-27 |
Compass Pathways plc. (4/27/21). "Press Release: Compass Pathways Launches Proposed Public Offering". London. |
2021-04-27 |
Endeavour Vision. (4/22/21). "Press Release: Endeavour Vision Closes Endeavour Medtech Growth II LP at USD 375m to Invest in Transformative Healthcare Technologies". St. Peter Port, Geneva & Minneapolis, MN. |
2021-04-22 |
Monument Therapeutics Ltd.. (4/22/21). "Press Release: Change of Director – Monument Therapeutics Is Pleased to Announce that Richard Bungay Will Join the Board as a Director with Immediate Effect". |
2021-04-22 |
OxVax Ltd.. (4/21/21). "Press Release: Cancer Vaccines Are Goal of New Oxford University Company. OxVax, a Spinout from Oxford University, Has Formed with the Objective of Producing Vaccines for Cancer". |
2021-04-21 |
Mestag Therapeutics Ltd.. (4/20/21). "Press Release: Mestag Therapeutics Launches with Seed Financing of $11 Million to Develop Therapeutics Targeting Activated Fibroblast Populations across Inflammatory Disease and Cancer". Cambridge. |
2021-04-20 |
Rinri Therapeutics Ltd.. (4/20/21). "Press Release: Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss". Sheffield. |
2021-04-20 |
Sense Biodetection Ltd.. (4/20/21). "Press Release: Sense Raises $50m Series B to Accelerate Launch of COVID-19 Molecular Test on Its Veros Instrument-free Product Platform". |
2021-04-20 |
Alchemab Therapeutics Ltd.. (4/15/21). "Press Release: Alchemab Raises £60 Million ($82 Million) in Series A Financing to Advance Novel Platform for Identifying Disease-modifying Antibody Therapeutics". Cambridge. |
2021-04-15 |
Ori Biotech Ltd.. (4/14/21). "Press Release: ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers". London & Woodcliff Lake, NJ. |
2021-04-14 |
Congenica Ltd.. (4/13/21). "Press Release: Congenica and Camtech Diagnostics Agree Strategic Partnership to Support Genomic Analysis Expansion in Asia". Cambridge & Singapore. |
2021-04-13 |
F2G Ltd.. (4/12/21). "Press Release: Francesco Maria Lavino Appointed Chief Executive Officer of F2G Ltd". Manchester & Vienna. |
2021-04-12 |
Future Planet Capital Ltd.. (4/8/21). "Press Release: Future Planet Acquires One of the UK’s Oldest VC Firms". |
2021-04-08 |
Artios Pharma Ltd.. (4/7/21). "Press Release: Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies". Cambridge & New York, NY. |
2021-04-07 |
LumiraDx Ltd.. (4/7/21). "Press Release: LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp". Boston, MA & London. |
2021-04-07 |
Oxford Biomedica plc. (5/6/21). "Press Release: Oxford Biomedica Signs a New Three Year Development & Supply Agreement with Boehringer Ingelheim for the Manufacture and Supply of Viral Vectors". Oxford. |
2021-04-06 |
Congenica Ltd.. (4/6/21). "Press Release: Congenica Appoints Jayesh Pankhania as Chief Financial Officer". Cambridge. |
2021-04-06 |
Achilles Therapeutics plc. (4/6/21). "Press Release: Achilles Therapeutics Announces Closing of $175.5 Million Initial Public Offering". London. |
2021-04-06 |
Valneva S.E.. (4/6/21). "Press Release: Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001". Saint-Herblain. |
2021-04-06 |
Metrion Biosciences Ltd.. (4/6/21). "Press Release: Metrion Biosciences Closes £2.7m New Equity Financing. Financing Led by Gresham House Ventures". Cambridge. |
2021-04-06 |
Achilles Therapeutics plc. (3/30/21). "Press Release: Achilles Therapeutics Announces Pricing of Initial Public Offering". London. |
2021-03-30 |
Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces Additional Financing Plans". London. |
2021-03-26 |
Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing". London. |
2021-03-26 |
Arix Bioscience plc. (3/24/21). "Press Release: Strategy Implementation Review". London. |
2021-03-24 |
PhoreMost Ltd.. (3/23/21). "Press Release: PhoreMost Closes £33M ($46M) Series B Financing". Cambridge. |
2021-03-23 |
Dunad Therapeutics. (3/23/21). "Press Release: Dunad Therapeutics Emerges to Develop Next-generation Small Molecule Therapeutics Based on First Tuneable Targeted Protein Degradation Technology". Cambridge. |
2021-03-23 |
Dotmatics Ltd.. (3/22/21). "Press Release: Insightful Science Joins Forces with Dotmatics to Form a Leading Cloud-First Scientific R&D Company". Bishop’s Stortford & San Diego, CA. |
2021-03-22 |
Aber Instruments. (3/22/21). "Press Release: Aber Introduces Futura neotf On-line Single-use Biomass Sensor". Aberystwyth. |
2021-03-22 |
Amphista Therapeutics Ltd.. (3/17/21). "Press Release: Amphista Therapeutics Raises $53M in Oversubscribed Series B Round to Advance Next Generation Targeted Protein Degradation Assets". Glasgow. |
2021-03-17 |
Axol Bioscience Ltd.. (3/17/21). "Press Release: Axol Bioscience and Censo Biotechnologies Announce Merger". Cambridge. |
2021-03-17 |
Vaccitech Ltd.. (3/17/21). "Press Release: Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results". Oxford. |
2021-03-17 |
Alchemab Therapeutics Ltd.. (3/16/21). "Press Release: Alchemab and Medicines Discovery Catapult to Develop Landmark Novel Antibody Therapy for Huntington’s disease". London. |
2021-03-16 |
CytoSeek Ltd.. (3/16/21). "Press Release: CytoSeek Raises £3.57M ($5M) to Advance Its Mission to Develop the Next Generation of Cell Therapies for Cancer". Bristol. |
2021-03-16 |
Antiverse Ltd.. (3/15/21). "Press Release: Antiverse Raises £1.4 Million ($2 Million USD) to Advance Its AI Antibody Drug Discovery Platform". |
2021-03-15 |
Touchlight Genetics Ltd.. (3/11/21). "Press Release: Touchlight Raises £42 Million ($58 Million) to Meet Unprecedented Global DNA Demand". Hampton. |
2021-03-11 |